Best TWAS P=1.57e-42 · Best GWAS P=1.61e-105 conditioned to 3.28e-08
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | IL33 | 0.09 | 0.07 | bslmm | 453 | 0.08 | 1.7e-09 | -8.1 | -8.5 | 2.2e-17 | -0.03 | 0.02 | 0.98 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | JAK2 | 0.09 | 0.02 | lasso | 5 | 0.03 | 1.0e-04 | 13.2 | -9.9 | 2.5e-23 | -0.53 | 0.73 | 0.06 | FALSE |
3 | CommonMind | Brain Pre-frontal Cortex | RCL1 | 0.10 | 0.07 | bslmm | 632 | 0.05 | 4.2e-07 | 13.1 | 13.7 | 1.6e-42 | 0.70 | 0.60 | 0.39 | TRUE |
4 | GTEx | Brain Cerebellum | SPATA6L | 0.41 | 0.01 | lasso | 7 | 0.09 | 1.7e-03 | 7.5 | 7.0 | 2.4e-12 | 0.06 | 0.15 | 0.05 | TRUE |
5 | GTEx | Breast Mammary Tissue | SPATA6L | 0.30 | 0.13 | lasso | 2 | 0.15 | 5.7e-08 | 9.5 | 8.8 | 1.4e-18 | 0.11 | 1.00 | 0.00 | FALSE |
6 | GTEx | Breast Mammary Tissue (Female) | SPATA6L | 0.31 | 0.07 | lasso | 4 | 0.07 | 4.4e-03 | 5.9 | 8.4 | 3.7e-17 | 0.09 | 0.13 | 0.05 | FALSE |
7 | GTEx | Cells Transformed fibroblasts | AK3 | 0.15 | 0.07 | lasso | 6 | 0.04 | 3.9e-04 | -1.9 | 5.3 | 1.2e-07 | 0.13 | 0.71 | 0.18 | TRUE |
8 | GTEx | Colon Transverse | SPATA6L | 0.44 | 0.25 | lasso | 8 | 0.26 | 6.4e-13 | 9.5 | 8.8 | 1.2e-18 | 0.14 | 1.00 | 0.00 | FALSE |
9 | GTEx | Esophagus Mucosa | SPATA6L | 0.24 | 0.26 | lasso | 2 | 0.27 | 2.0e-18 | 5.9 | 8.0 | 1.4e-15 | 0.09 | 1.00 | 0.00 | FALSE |
10 | GTEx | Muscle Skeletal | CDC37L1 | 0.14 | 0.08 | enet | 14 | 0.08 | 1.7e-08 | 8.3 | 6.8 | 1.0e-11 | 0.11 | 1.00 | 0.00 | FALSE |
11 | GTEx | Nerve Tibial | JAK2 | 0.17 | 0.08 | enet | 26 | 0.07 | 1.8e-05 | -6.2 | -8.5 | 1.6e-17 | -0.14 | 0.36 | 0.18 | TRUE |
12 | GTEx | Skin Not Sun Exposed Suprapubic | SPATA6L | 0.37 | 0.34 | enet | 23 | 0.34 | 2.4e-19 | 9.5 | 10.1 | 3.5e-24 | 0.15 | 1.00 | 0.00 | FALSE |
13 | GTEx | Skin Sun Exposed Lower leg | SPATA6L | 0.51 | 0.36 | lasso | 5 | 0.42 | 2.1e-37 | 9.5 | 9.0 | 2.2e-19 | 0.12 | 1.00 | 0.00 | FALSE |
14 | GTEx | Thyroid | SPATA6L | 0.37 | 0.31 | enet | 26 | 0.33 | 5.5e-26 | 9.5 | 9.7 | 2.1e-22 | 0.15 | 1.00 | 0.00 | FALSE |
15 | METSIM | Adipose | PPAPDC2 | 0.05 | 0.01 | enet | 21 | 0.01 | 2.9e-03 | 6.3 | 5.8 | 7.2e-09 | 0.07 | 0.78 | 0.01 | FALSE |
16 | ROSMAP | Brain Pre-frontal Cortex | SPATA6L | 0.08 | 0.00 | bslmm | 775 | 0.02 | 2.1e-03 | 6.8 | 6.9 | 5.2e-12 | 0.17 | 0.66 | 0.02 | FALSE |
17 | ROSMAP | Brain Pre-frontal Cortex | CDC37L1 | 0.09 | 0.07 | lasso | 3 | 0.08 | 4.6e-11 | 5.7 | -7.7 | 1.1e-14 | -0.09 | 1.00 | 0.00 | FALSE |
18 | ROSMAP | Brain Pre-frontal Cortex | KIAA1432 | 0.05 | 0.00 | blup | 502 | 0.02 | 7.5e-04 | 2.9 | 5.9 | 2.9e-09 | 0.10 | 0.12 | 0.02 | TRUE |
19 | ROSMAP | Brain Pre-frontal Cortex | RCL1 | 0.11 | 0.06 | bslmm | 641 | 0.07 | 9.3e-10 | -5.5 | -12.4 | 1.6e-35 | -0.65 | 0.38 | 0.62 | FALSE |
20 | ROSMAP | Brain Pre-frontal Cortex | IL33 | 0.20 | 0.17 | bslmm | 440 | 0.22 | 1.8e-28 | -8.1 | -8.0 | 9.7e-16 | -0.02 | 0.02 | 0.98 | FALSE |
21 | ROSMAP | Brain Pre-frontal Cortex | RP11-390F4.6 | 0.06 | 0.00 | blup | 566 | 0.02 | 1.2e-03 | -8.3 | 6.4 | 1.2e-10 | 0.03 | 0.02 | 0.92 | FALSE |
22 | ROSMAP | Brain Pre-frontal Cortex | IGHEP2 | 0.08 | 0.07 | enet | 12 | 0.08 | 3.7e-10 | 5.9 | -5.9 | 3.7e-09 | -0.03 | 1.00 | 0.00 | FALSE |
23 | YFS | Blood | PPAPDC2 | 0.19 | 0.11 | bslmm | 676 | 0.12 | 7.5e-38 | 9.5 | 10.5 | 5.5e-26 | 0.09 | 1.00 | 0.00 | FALSE |
24 | YFS | Blood | RCL1 | 0.10 | 0.09 | lasso | 1 | 0.09 | 4.4e-27 | -7.7 | -7.7 | 1.5e-14 | -0.34 | 1.00 | 0.00 | TRUE |
25 | The Cancer Genome Atlas | Breast Invasive Carcinoma | AK3 | 0.05 | 0.00 | blup | 79 | 0.01 | 1.0e-03 | -3.5 | 7.6 | 4.1e-14 | 0.20 | 0.01 | 0.07 | TRUE |
26 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C9orf68 | 0.11 | 0.10 | lasso | 4 | 0.11 | 6.1e-21 | 9.5 | 9.4 | 4.6e-21 | 0.11 | 0.00 | 1.00 | FALSE |
27 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C9orf68 | 0.09 | 0.04 | blup | 145 | 0.04 | 4.2e-05 | 8.3 | 8.1 | 5.1e-16 | 0.05 | 0.01 | 0.99 | FALSE |
28 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C9orf68 | 0.17 | 0.17 | enet | 10 | 0.15 | 7.2e-09 | 9.8 | 8.6 | 6.3e-18 | 0.11 | 0.00 | 1.00 | FALSE |
29 | The Cancer Genome Atlas | Brain Lower Grade Glioma | AK3 | 0.05 | 0.01 | blup | 79 | 0.02 | 2.2e-03 | -2.0 | 7.6 | 3.3e-14 | 0.25 | 0.03 | 0.13 | FALSE |
30 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C9orf68 | 0.18 | 0.05 | enet | 23 | 0.12 | 2.0e-13 | 3.8 | 6.5 | 7.3e-11 | 0.11 | 0.01 | 0.99 | FALSE |
31 | The Cancer Genome Atlas | Brain Lower Grade Glioma | IL33 | 0.07 | 0.07 | blup | 59 | 0.07 | 1.9e-08 | -8.1 | -8.5 | 1.7e-17 | -0.03 | 0.01 | 0.99 | TRUE |
32 | The Cancer Genome Atlas | Brain Lower Grade Glioma | PPAPDC2 | 0.08 | 0.03 | lasso | 6 | 0.04 | 6.0e-05 | 9.5 | 9.5 | 2.1e-21 | 0.13 | 0.00 | 1.00 | FALSE |
33 | The Cancer Genome Atlas | Brain Lower Grade Glioma | RCL1 | 0.04 | 0.02 | enet | 5 | 0.03 | 5.3e-04 | 9.3 | -11.3 | 9.0e-30 | -0.64 | 0.03 | 0.88 | TRUE |
34 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | C9orf68 | 0.17 | 0.15 | enet | 12 | 0.15 | 1.2e-06 | 9.5 | 10.0 | 1.7e-23 | 0.12 | 0.00 | 1.00 | FALSE |
35 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C9orf68 | 0.17 | 0.09 | enet | 39 | 0.15 | 3.0e-15 | 9.5 | 6.3 | 2.6e-10 | 0.07 | 0.00 | 1.00 | FALSE |
36 | The Cancer Genome Atlas | Prostate Adenocarcinoma | PPAPDC2 | 0.12 | 0.01 | enet | 14 | 0.04 | 9.4e-05 | -7.8 | 11.4 | 2.9e-30 | 0.03 | 0.01 | 0.82 | TRUE |
37 | The Cancer Genome Atlas | Thyroid Carcinoma | C9orf68 | 0.43 | 0.33 | enet | 28 | 0.34 | 9.3e-35 | 9.5 | 9.3 | 1.4e-20 | 0.10 | 0.01 | 0.99 | FALSE |
38 | The Cancer Genome Atlas | Thyroid Carcinoma | PPAPDC2 | 0.10 | 0.10 | enet | 6 | 0.11 | 1.3e-10 | 9.5 | -9.5 | 1.8e-21 | -0.13 | 0.01 | 0.99 | FALSE |
39 | The Cancer Genome Atlas | Thyroid Carcinoma | RCL1 | 0.06 | 0.03 | blup | 130 | 0.04 | 1.1e-04 | -7.7 | -10.5 | 6.1e-26 | -0.46 | 0.55 | 0.04 | TRUE |